SCANA ASA (SCANA.OL) Fundamental Analysis & Valuation

OSL:SCANANO0003053308

Current stock price

1.49 NOK
+0.02 (+1.71%)
Last:

This SCANA.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SCANA.OL Profitability Analysis

1.1 Basic Checks

  • In the past year SCANA was profitable.
  • SCANA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SCANA reported negative net income in multiple years.
  • SCANA had a positive operating cash flow in each of the past 5 years.
SCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFSCANA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.42%, SCANA is doing worse than 78.50% of the companies in the same industry.
  • SCANA has a Return On Equity of -5.78%. This is in the lower half of the industry: SCANA underperforms 77.57% of its industry peers.
Industry RankSector Rank
ROA -2.42%
ROE -5.78%
ROIC N/A
ROA(3y)2.56%
ROA(5y)3.28%
ROE(3y)6.37%
ROE(5y)7.25%
ROIC(3y)N/A
ROIC(5y)N/A
SCANA.OL Yearly ROA, ROE, ROICSCANA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

1.3 Margins

  • SCANA has a Gross Margin of 57.49%. This is in the better half of the industry: SCANA outperforms 79.44% of its industry peers.
  • SCANA's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SCANA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.36%
GM growth 5Y5.31%
SCANA.OL Yearly Profit, Operating, Gross MarginsSCANA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 -60

3

2. SCANA.OL Health Analysis

2.1 Basic Checks

  • SCANA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SCANA remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for SCANA has been increased compared to 5 years ago.
  • SCANA has a worse debt/assets ratio than last year.
SCANA.OL Yearly Shares OutstandingSCANA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
SCANA.OL Yearly Total Debt VS Total AssetsSCANA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • SCANA has a debt to FCF ratio of 3.56. This is a good value and a sign of high solvency as SCANA would need 3.56 years to pay back of all of its debts.
  • SCANA has a better Debt to FCF ratio (3.56) than 63.55% of its industry peers.
  • A Debt/Equity ratio of 0.53 indicates that SCANA is somewhat dependend on debt financing.
  • SCANA has a Debt to Equity ratio of 0.53. This is comparable to the rest of the industry: SCANA outperforms 42.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 3.56
Altman-Z N/A
ROIC/WACCN/A
WACC8.06%
SCANA.OL Yearly LT Debt VS Equity VS FCFSCANA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • SCANA has a Current Ratio of 1.03. This is a normal value and indicates that SCANA is financially healthy and should not expect problems in meeting its short term obligations.
  • SCANA's Current ratio of 1.03 is on the low side compared to the rest of the industry. SCANA is outperformed by 82.24% of its industry peers.
  • SCANA has a Quick Ratio of 1.03. This is a bad value and indicates that SCANA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SCANA has a Quick ratio of 0.83. This is in the lower half of the industry: SCANA underperforms 61.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.83
SCANA.OL Yearly Current Assets VS Current LiabilitesSCANA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. SCANA.OL Growth Analysis

3.1 Past

  • The earnings per share for SCANA have decreased strongly by -144.13% in the last year.
  • Measured over the past years, SCANA shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.20% on average per year.
  • SCANA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -18.95%.
  • SCANA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.74% yearly.
EPS 1Y (TTM)-144.13%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%966.67%
Revenue 1Y (TTM)-18.95%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%0.42%

3.2 Future

  • The Earnings Per Share is expected to decrease by -4.89% on average over the next years.
  • The Revenue is expected to decrease by -1.06% on average over the next years.
EPS Next Y-118.21%
EPS Next 2Y-20.75%
EPS Next 3Y-4.89%
EPS Next 5YN/A
Revenue Next Year-16.93%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.06%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SCANA.OL Yearly Revenue VS EstimatesSCANA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
SCANA.OL Yearly EPS VS EstimatesSCANA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 0.05 0.1 0.15

6

4. SCANA.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 9.31, which indicates a very decent valuation of SCANA.
  • SCANA's Price/Earnings ratio is rather cheap when compared to the industry. SCANA is cheaper than 95.33% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SCANA to the average of the S&P500 Index (27.95), we can say SCANA is valued rather cheaply.
  • The Price/Forward Earnings ratio is 14.47, which indicates a correct valuation of SCANA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SCANA indicates a somewhat cheap valuation: SCANA is cheaper than 67.29% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.68, SCANA is valued rather cheaply.
Industry RankSector Rank
PE 9.31
Fwd PE 14.47
SCANA.OL Price Earnings VS Forward Price EarningsSCANA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SCANA's Enterprise Value to EBITDA ratio is in line with the industry average.
  • SCANA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SCANA is cheaper than 89.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.19
EV/EBITDA 10.07
SCANA.OL Per share dataSCANA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • SCANA's earnings are expected to decrease with -4.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.44
EPS Next 2Y-20.75%
EPS Next 3Y-4.89%

0

5. SCANA.OL Dividend Analysis

5.1 Amount

  • SCANA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SCANA.OL Fundamentals: All Metrics, Ratios and Statistics

SCANA ASA

OSL:SCANA (4/17/2026, 7:00:00 PM)

1.49

+0.02 (+1.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners2.94%
Inst Owner ChangeN/A
Ins Owners2.43%
Ins Owner ChangeN/A
Market Cap688.22M
Revenue(TTM)1.60B
Net Income(TTM)-36.30M
Analysts86.67
Price Target1.94 (30.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2219.14%
Min EPS beat(2)-100%
Max EPS beat(2)4538.28%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-10.47%
Max Revenue beat(2)8.79%
Revenue beat(4)2
Avg Revenue beat(4)-4.62%
Min Revenue beat(4)-19.55%
Max Revenue beat(4)8.79%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.31
Fwd PE 14.47
P/S 0.43
P/FCF 5.19
P/OCF 3.83
P/B 1.1
P/tB 2.78
EV/EBITDA 10.07
EPS(TTM)0.16
EY10.74%
EPS(NY)0.1
Fwd EY6.91%
FCF(TTM)0.29
FCFY19.25%
OCF(TTM)0.39
OCFY26.1%
SpS3.46
BVpS1.36
TBVpS0.54
PEG (NY)N/A
PEG (5Y)0.44
Graham Number2.21274 (48.51%)
Profitability
Industry RankSector Rank
ROA -2.42%
ROE -5.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.49%
FCFM 8.3%
ROA(3y)2.56%
ROA(5y)3.28%
ROE(3y)6.37%
ROE(5y)7.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.36%
GM growth 5Y5.31%
F-Score4
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 3.56
Debt/EBITDA 3.04
Cap/Depr 38.39%
Cap/Sales 2.95%
Interest Coverage N/A
Cash Conversion 163.57%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.83
Altman-Z N/A
F-Score4
WACC8.06%
ROIC/WACCN/A
Cap/Depr(3y)47.82%
Cap/Depr(5y)37.5%
Cap/Sales(3y)3.07%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-144.13%
EPS 3Y-9.23%
EPS 5Y21.2%
EPS Q2Q%966.67%
EPS Next Y-118.21%
EPS Next 2Y-20.75%
EPS Next 3Y-4.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.95%
Revenue growth 3Y84.93%
Revenue growth 5Y39.74%
Sales Q2Q%0.42%
Revenue Next Year-16.93%
Revenue Next 2Y-4.58%
Revenue Next 3Y-1.06%
Revenue Next 5YN/A
EBIT growth 1Y-108.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2728.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.29%
FCF growth 3Y37.83%
FCF growth 5Y28.39%
OCF growth 1Y22.59%
OCF growth 3Y36.91%
OCF growth 5Y35.69%

SCANA ASA / SCANA.OL Fundamental Analysis FAQ

What is the fundamental rating for SCANA stock?

ChartMill assigns a fundamental rating of 3 / 10 to SCANA.OL.


Can you provide the valuation status for SCANA ASA?

ChartMill assigns a valuation rating of 6 / 10 to SCANA ASA (SCANA.OL). This can be considered as Fairly Valued.


What is the profitability of SCANA stock?

SCANA ASA (SCANA.OL) has a profitability rating of 3 / 10.


What are the PE and PB ratios of SCANA ASA (SCANA.OL) stock?

The Price/Earnings (PE) ratio for SCANA ASA (SCANA.OL) is 9.31 and the Price/Book (PB) ratio is 1.1.


What is the financial health of SCANA ASA (SCANA.OL) stock?

The financial health rating of SCANA ASA (SCANA.OL) is 3 / 10.